Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation for Sustained Remission in SSNS
NCT06860620Completed
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of zinc in nephrotic syndrome (2 arms). Primary endpoint: Sustained remission at 6 months. Started Jan 2024; status: completed.
02
Drugs
zinc
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT06860620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06860620.